Search images on Google Product Monograph
Active Ingredients:
- tremelimumab, 20 MG/ML
DIN: 02541009
Dosage Form(s): SOLUTION
Route(s) of Administration: INTRAVENOUS
Schedule: Prescription
Company: ASTRAZENECA CANADA INC – official site
ATC:
- L01 - ANTINEOPLASTIC AGENTS (ATC, WHO, Wiki)
- L01 - ANTINEOPLASTIC AGENTS (ATC, WHO)
- L01 - ANTINEOPLASTIC AGENTS (ATC, WHO)
- L01 - ANTINEOPLASTIC AGENTS (WHO)
Pharmaceutical standard: MFR
External Links for Imjudo:
Search on Google
Astrazeneca Canada Inc
Go to AstraZeneca website to see drug product details. Sometimes you can find imjudo photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.